Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Bausch Health Companies Inc’s stock clocked out at $6.38, up 2.90% from its previous closing price of $6.2. In other words, the price has increased by $2.90 from its previous closing price. On the day, 3.07 million shares were traded. BHC stock price reached its highest trading level at $6.425 during the session, while it also had its lowest trading level at $6.2.
Ratios:
To gain a deeper understanding of BHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 13 ’25 when Paulson John bought 3,564,059 shares for $5.94 per share. The transaction valued at 21,170,510 led to the insider holds 32,791,702 shares of the business.
Paulson John bought 1,005,376 shares of BHC for $5,499,407 on Jun 12 ’25. The Director now owns 29,227,643 shares after completing the transaction at $5.47 per share. On Jun 11 ’25, another insider, Paulson John, who serves as the Director of the company, bought 1,029,098 shares for $5.24 each. As a result, the insider paid 5,392,474 and bolstered with 28,222,267 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2357729024 and an Enterprise Value of 23676729344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24. Its current Enterprise Value per Revenue stands at 2.433 whereas that against EBITDA is 7.665.
Stock Price History:
The Beta on a monthly basis for BHC is 0.33, which has changed by -0.074020326 over the last 52 weeks, in comparison to a change of 0.111126065 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.85, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is 26.63%, while the 200-Day Moving Average is calculated to be -7.70%.
Shares Statistics:
It appears that BHC traded 2.49M shares on average per day over the past three months and 4148200 shares per day over the past ten days. A total of 369.54M shares are outstanding, with a floating share count of 290.67M. Insiders hold about 21.34% of the company’s shares, while institutions hold 58.47% stake in the company. Shares short for BHC as of 1748563200 were 8606924 with a Short Ratio of 3.46, compared to 1745971200 on 9864778. Therefore, it implies a Short% of Shares Outstanding of 8606924 and a Short% of Float of 2.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 6.52.
